• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

‘Simple, but powerful’ model reveals mechanisms behind…

Bioengineer.org by Bioengineer.org
January 20, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: The Scripps Research Institute

JUPITER, Fla. – Dec. 18, 2017 – All things must come to an end. This is particularly true for neurons, especially the extensions called axons that transmit electrochemical signals to other nerve cells. Without controlled termination of individual neuron growth, the efficient and accurate construction of a nervous system is in serious jeopardy.

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have now uncovered new insights into the regulatory network behind that termination. The study, led by TSRI Associate Professor Brock Grill, PhD, was recently published online ahead of print in the journal Development.

The scientists focused on axons, long cellular structures that project outward from the neuron body. When nerve cells fire, it's the axon that transmits the electrochemical signal to other neurons. Over the course of their development, axons extend, change their growth in response to cellular guidance cues and form synapses.

At the heart of this process is a specialized structure on the end of each axon called a growth cone. Successful development depends on the growth cone stopping at the correct destination and when the axon is the correct length, a process known as axon termination.

Using the nematode worm C. elegans as a model, Grill and his colleagues found for the first time that growth cone collapse prior to axon termination is protracted as the growth cone transitions from a dynamic to a static state.

"We know very little about the process of how axons actually stop growing in a living animal," Grill says. "What we found in our simple, but powerful model is that a signaling hub protein called RPM-1 is required to regulate the collapse of growth cones during axon termination."

It's the protracted nature of the process, Grill says, that is likely to make the transition-and the termination-permanent.

These findings provide new details on how growth cone collapse is regulated during axon termination in vivo. The study also shows that RPM-1 signaling destabilizes nerve cell microtubules-large molecules that provide critical cell structure-to facilitate growth cone collapse and axon termination.

When the scientists looked at the relationship between RPM-1 and other regulators of microtubule stability, they were surprised by the results.

They found that that while RPM-1 signaling destabilizes axon microtubules, the microtubule stabilizer Tau potentially inhibits RPM -1, something that was previously unknown. "People have very little knowledge about how TAU works under normal physiological conditions," says TSRI Research Associate Melissa Borgen, PhD, first author of the study.

"Our results suggest that Tau inhibition of RPM-1 is necessary for proper axon development, and offers the first evidence that RPM-1 can be regulated in vivo in neurons."

The research has implications for the development of neurological disorders as well. In mouse models, RPM-1 is an active force in axon degeneration and TAU has been linked to neurological disorders, including Alzheimer's disease and frontal temporal dementia.

"You wouldn't necessarily have thought Tau and RPM-1 would function this way," Grill says. "That's the power of genetics. Although we assessed the genetic relationship between Tau and RPM-1 in axon development, our results could have important implications for neurodegeneration."

###

In addition to Grill and Borgen, the other author of the study, "RPM-1 Regulates Axon Termination by Affecting Growth Cone Collapse and Microtubule Stability," is Dandan Wang, PhD, of TSRI.

The study was supported by the National Institutes of Health (grant R01 NS072129) and the National Science Foundation (grant IOS-1121095).

Media Contact

Stacey Singer DeLoye
[email protected]
561-228-2551
@scrippsresearch

http://www.scripps.edu

Share12Tweet8Share2ShareShareShare2

Related Posts

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.